Cantharidin enhances norepinephrine-induced vasoconstriction in an endothelium-dependent fashion

Journal of Pharmacology and Experimental Therapeutics

Volumn 294, Issue 2, 2000, Pages 620-626

  Knapp, Jörg ^a   Bokník, Peter ^a   Linck, Bettina ^a   Lüss, Hartmut ^a   Müller, Frank U ^a   Petertönjes, Lars ^a   Schmitz, Wilhelm ^a   Neumann, Joachim ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANTHARIDIN; MYOSIN LIGHT CHAIN; NORADRENALIN; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; REGULATOR PROTEIN;

ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

ANIMALS; AORTA, THORACIC; CANTHARIDIN; CATALYSIS; DRUG SYNERGISM; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN PHOSPHATASE; NOREPINEPHRINE; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; RATS; RATS, WISTAR; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0033929278     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Alosachie I and Godfraind T (1988) The modulatory role of vascular endothelium in the interaction of agonists and antagonists with α-adrenoceptors in the rat aorta. Br J Pharmacol 95:619-629.
2. Bockman CS, Gonzales-Cabrera I and Abel PW (1996) Alpha-2 adrenoceptor subtype causing nitric oxide-mediated vascular relaxation in rats. J Pharmacol Exp Ther 278:1235-1243.
3. Bokník P, Unkel C, Kirchhefer U, Kleideiter U, Klein-Wiele O, Knapp J, Linck B, Lüss H, Müller FU, Schmitz W Vahlensieck U, Zimmermann N, Jones LR and Neumann J (1999) Regional expression of phoapholamban in the human heart. Cardiovasc Res 42:67-76.
4. Bradford MM (1976) A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
5. Bredt DS, Ferris CD and Snyder SH (1992) Nitric oxide synthase regulatory sites. J Biol Chem 267:10976-10981.
6. Calovini T, Haase HAND and Morano I (1995) Steroid-hormone regulation of myosin subunit expression in smooth muscle and cardiac muscle. J Cell Biochem 59:69-78.
7. Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Monellano PR and Kemp BE (1999) AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443:285-289.
8. Cocks TM and Angus JA (1983) Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature (Lond) 305:627-630.
9. Cohen P (1989) The structure and regulation of protein phosphatases. Annu Rev Biochem 58:453-508.
10. Cohen P, Holmes CFB and Taukitani Y (1990) Okadaic acid: A new probe for the study of cellular regulation. Trends Biochem Sci 15:98-102.
11. Eldridge R and Casida JE (1995) Cantharidin effects on protein phosphatases and the phosphorylation state of phosphoproteins in mice. Toxicol Appl Pharmacol 130:95-100.
12. Erdödi F, Toth B, Hirano K, Hirano M, Hartshorne DJ and Gergely P (1995) Endothall thioanhydride inhibits protein phosphatases-1 and 2A in vivo. Am J Physiol 269:C1176-C1184.
13. Erdödi F, Ito M and Hartshorne DJ (1996) Myosin light chain phosphatase, in Biochemistry of Smooth Muscle Contraction (Barany M ed) pp 131-142, Academic Press, San Diego.
14. Goeckeler ZM and Wysolmerski RB (1995) Myosin light chain kinase-regulated endothelial cell contraction: The relationship between isometric tension, actin polymerization, and myosin phosphorylation. J Cell Biol 130:613-627.
15. Gong MC, Cohen P, Kitazawa T, Ikebe M, Masatoshi M, Somlyo AP and Somlyo AV (1992) Myosin light chain phosphatase activities end the effects of phosphatase inhibitors in tonic and phasic smooth muscle. J Biol Chem 267:14662-14668.
16. Gray DW and Marshall I (1992) Novel signal transduction pathway mediating endothelium-dependent β-adrenoceptor vasorelaxation in rat thoracic aorta. Br J Pharmacol 107:684-690.
17. Haase H and Morano I (1996) Alternative splicing of smooth muscle myosin heavy chains and its functional consequences. J Cell Biochem 60:521-528.
18. Herzig S and Neumann J (2000) Effects of serine/threonine protein phosphatases on ion channels in excitable membranes. Physiol Rev 80:173-210.
19. Honkanen RE (1993) Cantharidin, another natural toxin that inhibits the activity of senne/threonine protein phosphatases types 1 and 2A. FEBS Lett 330:283-286.
20. Jin N, Siddiqui RA, English D and Rhoades RA (1996) Communication between tyrosine kinase pathway and myosin light chain kinase pathway in smooth muscle. Am J Physiol 271:H1348-H1355.
21. Kitazawa T, Masuo M and Somlyo AP (1991) G protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle. Proc Natl Acad Sci USA 88:9307-9310.
22. Knapp J, Bokník P, Deng MC, Huke S, Klein-Wiele O, Linck B, Lüss H, Lüss I, Müller FU, Nacke P, Scheld HH, Schmitz W, Vahlensieck U and Neumann J (1999a) On the contractile function of protein phosphatases in isolated human coronary arteries. Naunyn-Schmiedeberg's Arch Pharmacol 360:464-472.
23. Knapp J, Bokník P, Huke S, Lüss H, Müller FU, Müller T, Nacke P, Schmitz W, Vahlensieck U and Neumann J (1998) The mechanism of action of cantharidin in smooth muscle. Br J Pharmacol 123:911-919.
24. Knapp J, Bokník P, Linck B, Lüss H, Müller FU, Nacke P, Neumann J, Vahlensieck U and Schmitz W (1997) The effect of the protein phosphatases inhibitor cantharidin on β-adrenoceptor-mediated vasorelaxation. Br J Pharmacol 120:421-428.
25. Knapp J, Bokník P, Lüss I, Huke S, Linck B, Lüss H, Müller FU, Müller T, Nacke P, Noll T, Piper HM, Schmitz W, Vahlensieck U and Neumann J (1999b) The protein phosphatase inhibitor cantharidin alters vascular endothelial cell permeability. J Pharmacol Exp Ther 289:1480-1486.
26. 3H]Cantharidin binding site in relation to cytotoxicity. J Pharmacol Exp Ther 280:1152-1158.
27. Linck B, Boknik P, Knapp J, Müller FU, Neumann J, Schmitz W and Vahlensieck U (1996) Effects of cantharidin on force of contraction and phosphatase activity in nonfailing and failing human hearts. Br J Pharmacol 119:545-550.
28. Neumann J, Bokník P, Herzig S, Schmitz W, Scholz H, Gupta RC and Watanabe AM (1993) Evidence for physiological functions of protein phosphatases in the heart: Evaluation with okadaic acid. Am J Physiol 265:H257-H266.
29. Neumann J, Herzig S, Bokník P, Apel M, Kaspareit G, Schmitz W, Scholz H, Tepel M and Zimmermann N (1995) On the cardiac contractile, biochemical and electrophysiological effects of cantharidin, a phosphatase inhibitor. J Pharmacol Exp Ther 274:530-539.
30. Sase K and Michel T (1997) Expression and regulation of endothelial nitric oxide synthase. Trends Cardiovasc Med 7:28-37.
31. Seasholtz TM, Gurdal H, Wang HY, Johnson MD and Friedman E (1997) Desensitization of norepinephrine receptor function is associated with G protein uncoupling in the rat aorta. Am J Physiol 273:H279-H285.
32. Shenolikar S and Nairn AC (1991) Protein phosphatases: Recent progress, in Advances in Second Messenger and Phosphoprotein Research (Greengard P and Robinson GA eds) pp 1-121, Raven Press, New York.
33. Shirazi A, Iizuka K, Fadden P, Mosse C, Somlyo AP, Somlyo AV and Haystead TAJ (1994) Purification and characterization of the mammalian myosin light chain phosphatase holoenzyme. J Biol Chem 269:31598-31606.
34. Simmerman HKB and Jones LR (1998) Phospholamban: Protein structure, mechanism of action, and role in cardiac function. Physiol Rev 78:921-947.
35. Somlyo AP and Somlyo AV (1994) Signal transduction and regulation in smooth muscle. Nature (Lond) 372:231-236.
36. Sutliff RL, Hoying JB, Kadambi VJ, Kranias EG and Paul RJ (1999) Phospholamban is present in endothelial cells and modulates endothelium-dependent relaxation. Circ Res 84:360-364.
37. 2+ levels, myosin light chain phosphorylation and force in vascular smooth muscle. Naunyn-Schmiedeberg's Arch Pharmacol 354:120-127.
38. Urabe M, Kawasaki H and Takasaki K (1991) Effect of endothelium removal on the vasoconstrictor response to neuronally released 5-hydroxytryptamine and noradrenaline in the rat isolated mesenteric and femoral arteries. Br J Pharmacol 102:85-90.
39. Waurick R, Knapp J, Van Aken H, Bokník P, Neumann J and Schmitz W (1999) Effect of 2,3-butanedione monoxime on force of contraction and protein phosphorylation in bovine smooth muscle. Naunyn-Schmiedeberg's Arch Pharmacol 359: 484-492.
40. Wera S and Hemmings BA (1995) Serine/threonine protein phosphatases. Biochem J 311:17-29.
41. 1-adrenoceptor subtypes in aortas of 12-month-old spontaneously hypertensive rats. Eur J Pharmacol 344:31-36.